Jagsonpal Pharma to acquire 85% of Aequitas Healthcare for ₹20.8 Cr

Jagsonpal Pharmaceuticals Ltd has entered into a Share Purchase Agreement (SPA) to acquire 85% of the paid-up equity share capital of Aequitas Healthcare Private Limited for a cash consideration of ₹20.8 Crore. Aequitas Healthcare is engaged in the sale and distribution of pharmaceutical products to hospitals. This acquisition aligns with Jagsonpal's strategic objective to gain access to the hospital channel and institutional doctor network, thereby reducing the time required for organic relationship building. The acquisition is expected to be completed by July 15, 2026, and does not require any governmental or regulatory approvals. Aequitas Healthcare reported a revenue of ₹53.31 crores in FY 2025-26.